Which antihypertensive agents in chronic kidney disease?

Editorial

Andrew S Levey et al. Ann Intern Med. 2006.

. 2006 Feb 7;144(3):213-5.

doi: 10.7326/0003-4819-144-3-200602070-00011.

Erratum in

No abstract available

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group. Rahman M, et al. Ann Intern Med. 2006 Feb 7;144(3):172-80. doi: 10.7326/0003-4819-144-3-200602070-00005. Ann Intern Med. 2006. PMID: 16461961 Clinical Trial.

Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.
O'Hare AM, Rodriguez RA, Bowling CB. O'Hare AM, et al. Nephrol Dial Transplant. 2016 Mar;31(3):368-75. doi: 10.1093/ndt/gfv003. Epub 2015 Jan 29. Nephrol Dial Transplant. 2016. PMID: 25637639 Free PMC article. Review.
Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.
O'Hare AM, Hotchkiss JR, Kurella Tamura M, Larson EB, Hemmelgarn BR, Batten A, Do TP, Covinsky KE. O'Hare AM, et al. JAMA Intern Med. 2014 Mar;174(3):391-7. doi: 10.1001/jamainternmed.2013.13328. JAMA Intern Med. 2014. PMID: 24424348 Free PMC article.